Landmark India IP Board Decision Against Hepatitis C Drug Patent
India last week saw a landmark public health decision on the evolving role of intellectual property rights in the context of the public interest.
Original news and analysis on international IP policy
India last week saw a landmark public health decision on the evolving role of intellectual property rights in the context of the public interest.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) held its 26th assembly this week and elected its new president. He presented the future orientation of the industry group, saying will work on trust-building and needs predictability in the regulatory process, policies that sustain and encourage innovation, and a strong intellectual property system, he said.
This week, members of a consortium sponsored by the World Intellectual Property Organization to facilitate research in neglected diseases celebrated the first anniversary of the initiative and claimed an expanding membership and several research collaborations or agreements.
A new petition circulating worldwide urges the delay of a suddenly fast-moving proposal to create a Pan-African Intellectual Property Organization (PAIPO). The delay effort – which seeks an open discussion of the proposal to make it more tailored to local African needs - comes just weeks before African Union representatives meet to consider its adoption.
In a single voice, public health authorities spoke out about the need to take on the world’s heaviest disease burdens including cancer, diabetes, cardiovascular and chronic respiratory diseases. Now negotiations are narrowing in on the specifics of how to prevent and control these diseases, and achieving agreement on some commitments, including those related to medicine availability, could prove more challenging.
At last week's high-level meeting of the UN Convention on Biological Diversity (CBD) governments agreed to double financial flows toward biodiversity by 2015, the CBD has announced. They also came up with strategy to move forward on access and benefit-sharing of biodiversity.
Honduras has submitted a request for the formation of a dispute settlement panel at the World Trade Organization regarding a tobacco plain-packaging law Australia has passed for public health reasons.
The first meeting of the World Health Organization member state mechanism to prevent and control so-called substandard, spurious, falsely-labelled, falsified, and counterfeit medical products (SSFFC) will be held in Buenos Aires, Argentina from 19-21 November.
The Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria is in the final phases of selecting its next executive director. In the run-up to the decision, the international financing institution is multiplying signs of its good health as it looks to turn a corner after months of major reforms.
Global health needs innovation but also to ensure equitable access for the world population, panellists at a roundtable said last week. At issue is the capacity of the pharmaceutical industry to innovate, and the potential barriers to access in a context of widespread diseases that blur the boundaries between developed and developing countries. Most panellists concluded that governments should hold primary responsibility for the health of their populations.
Members of the World Intellectual Property Organization this week could not agree on a work plan for the WIPO Standing Committee on the Law of Patents (SCP), leading to a likely postponement of the next committee meeting. In addition, the annual WIPO General Assemblies failed to agree to hold a diplomatic conference on a Design Law Treaty, but did agree on an expedited way forward. And the Assemblies took note of the work of the committees on standards and enforcement.
The World Health Organization advisory group on pandemic influenza preparedness met with pharmaceutical industry representatives, civil society members, and other stakeholders last week to move toward a recommendation on a partnership contribution formula to determine payment modalities for influenza virus sharing.